Tag Archives:mTOR signalling
Expression of mTOR-signalling pathway proteins in skin squamous-cell carcinomas before and after conversion to mTOR-inhibitors
Inhibitors of the Mammalian Target of Rapamycin (mTORis) are drugs exerting both immunosuppressive and antitumor effects, and are thereby used in organ-transplant recipients (OTR) in order to both prevent allograft rejection and to reduce the risk of
